Atlas Trials

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

Clinical trial NCT00346645 · TERMINATED

Trial details

NCT number
NCT00346645
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER
Start date
2006-06-01
Primary completion
2007-05-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.